Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Taylor Sandison, MD, MPH
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
132 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alexander Fleming Specialized Medical Institute
Buenos Aires, Argentina
- Allende Sanatorium
Córdoba, Argentina
- Cordoba Private Hospital
Córdoba, Argentina
- Mayo Private Sanatorium
Córdoba, Argentina
- Italian Hospital of Mendoza
Mendoza, Argentina
- Westmead Public Hospital
Northmead, New South Wales, Australia
- Monash Health
Clayton, Victoria, Australia
- Alfred Health
Melbourne, Victoria, Australia
- Peter Maccallum Cancer Centre
Melbourne, Victoria, Australia
- Royal Melbourne Hospital (rmh)
Parkville, Victoria, Australia
- Brugmann University Hospital Center
Brussels, Belgium
- Erasme Hospital
Brussels, Belgium
- Saint Luc University Hospital
Brussels, Belgium
- University Hospital Brussels
Brussels, Belgium
- University Hospitals Leuven, Campus Gasthuisberg
Leuven, Belgium
- Multiprofile Hospital for Active Treatment Puls
Blagoevgrad, Bulgaria
- University Multiprofile Hospital for Active Treatment and Emergency Medicine N.I. Pirogov Ead
Sofia, Bulgaria
- University Multiprofile Hospital for Active Treatment and Emergency Medicine N.I. Pirogov Ead, Sofia, Clinic of Purulent-Septic Surgery
Sofia, Bulgaria
- the First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, China
- the Second Hospital of Anhui Medical University
Hefei, Anhui, China
- the Second People'S Hospital of Hefei
Hefei, Anhui, China
- Chongqing People'S Hospital
Chongqing, Chongqing Municipality, China
- Guangdong Provincial People'S Hospital
Guangzhou, Guangdong, China
- Guangzhou First People'S Hospital
Guangzhou, Guangdong, China
- the First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
- Qingyuan People'S Hospital
Qingyuan, Guangdong, China
- Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China
- the Second Xiangya Hospital of Central South University
Changsha, Hunan, China
- Nanjing First Hospital
Nanjing, Jiangsu, China
- Zibo Central Hospital
Zibo, Shandong, China
- West China Hospital, Sichuan University
Chengdu, Sichuan, China
- Huashan Hospital Affiliated Fudan University
Shanghai, China
- Shanghai Pulmonary Hospital
Shanghai, China
- General Hospital of Tianjin Medical University
Tianjin, China
- Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences
Tianjin, China
- Cequin Foundation Cardiomet
Armenia, Colombia
- de la Costa Clinic Ltd.
Barranquilla, Colombia
- University Ips - Leon Xiii Clinic
Medellín, Colombia
- Amiens Picardie University Hospital - South
Amiens, France
- Centre Hospitalier Victor Dupouy - Argenteuil
Argenteuil, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Oct 2018
- Primary completion
- 7 Oct 2021
- Completion
- 7 Oct 2021
- Last update posted
- 6 Jan 2023
- Registered enrollment
- 199
- Registry id
- NCT03667690
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.